OBIO’s 2025 Investment Summit – Feb 5-7 in Toronto, ON – will spotlight Canada’s most investable health science companies across therapeutics, devices, diagnostics & digital health sectors, and will feature a mixture of company pitches, keynote presentations and one-on-one meetings.
To be considered for the first round of review, companies should submit an application before November 1, 2024. Applications are being reviewed on a rolling basis with limited presentation spots per financing stage: spin-out, pre-seed, seed, and series A+. The final deadline is November 22, 2024.
Since 2018, over 200 Canadian health science companies have presented at the OBIO® Investment Summit and the companies that have presented have raised over $1.6 billion in investment and over $2 billion in mergers & acquisitions and licensing.
Feb 5-7, 2025
Toronto, ON
Learn more about OBIO 2025 Investment Summit
